Allarity Therapeutics, Inc. (ALLR) vs Citius Pharmaceuticals, Inc. (CTXR)
A side-by-side comparison of Allarity Therapeutics, Inc. and Citius Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$0.98HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
CTXR
Citius Pharmaceuticals, Inc.
$0.48HealthcareDelayed quote: Oct 6, 2026, 2:58 PM EDT
Total return — ALLR vs CTXR
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)CTXR -98.7% (-57.9%/yr)CTXR compounded faster over this window
Log scale — wide-divergence pair
ALLR CTXR
ALLR vs CTXR: by the numbers
- •ALLR is the larger company ($16M vs $13M market cap).
- •Both run net losses; CTXR's is the smaller (-651.27% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | CTXR |
|---|---|---|
| P/S ratio | 45.37 | 1.86 |
| P/B ratio | 4.43 | 0.20 |
Profitability
| Metric | ALLR | CTXR |
|---|---|---|
| Gross margin | 107.54% | 0.00% |
| Operating margin | -3939.06% | 0.00% |
| Net margin | -3575.07% | -651.27% |
| ROE | -348.81% | -69.47% |
| ROIC | -41.81% | -67.62% |
Growth (annualized)
| Metric | ALLR | CTXR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -60.04% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.